Skip to content

Clinical study of low intensity ultrasound nerve stimulation in the treatment of post-stroke anxiety and depression

Clinical study of low intensity ultrasound nerve stimulation in the treatment of post-stroke anxiety and depression

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000035582
Enrollment
Unknown
Registered
2020-08-16
Start date
2020-10-01
Completion date
Unknown
Last updated
2020-08-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post stroke anxiety and depression

Interventions

Experimental group:Low intensity ultrasound treatment
Control group:Conventional treatment

Sponsors

Xinhua Hospital Affiliated to Medical College of Shanghai Jiaotong University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. The subjects signed the informed consent of the trial voluntarily; 2. Confirmed stroke sequelae patients: aged 60 years or older, less than or equal to 80 years old, regardless of gender, onset more than 30 days; 3. The diagnostic criteria were as follows: 1) The diagnosis was stroke sequelae; 2) Patients with depression and anxiety were diagnosed by DSM5; 3) Aged 60-80 years old; 4) Currently, there is no antidepressant and anti anxiety medication; 5) Normal renal and cardiac function was not found; 6) Understand the procedure and method of the trial, voluntarily and strictly abide by the clinical trial protocol to complete the trial, and sign the informed consent; 4. The subjects were able to follow the drug dosage and visit plan; 5. Objective description of symptoms, no serious infection, respiratory insufficiency, etc., can actively cooperate; 6. No allergic disease, non allergic constitution. 7. There were no drug abusers or addicts; 8. There was no clinical trial within 3 months before the trial.

Exclusion criteria

Exclusion criteria: 1. The general situation is poor, can not objectively describe the symptoms, or can not take the initiative to cooperate; 2. Patients with severe respiratory system, cardiovascular system disease, liver and kidney dysfunction, malignant tumor; 3. People with allergic diseases and allergic constitution; 4. Those who suspected or had a history of drug abuse and addiction; 5. Those who participated in clinical trials within 3 months before the trial; 6. The sponsor or researcher directly involved in the trial or their family members; 7. The researchers thought that there was any reason why they could not be selected.

Design outcomes

Primary

MeasureTime frame
Depression assessment form for phq-9 patients;Gad-7 anxiety screening scale;

Secondary

MeasureTime frame
Quality of life questionnaire qol;

Countries

China

Contacts

Public ContactDuan Junli

Xinhua Hospital Affiliated to Medical College of Shanghai Jiaotong University

duanjunlixh@163.com+86 13651626960

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026